Deerfield Private Design Fund III, L.P. is 10% Owner at ARS Pharmaceuticals, Inc. (SPRY). They have made 4 open-market trades across 4 companies since 2015, most recently 2024-11-12.
CIK 0001603333
2 open-market purchases totalling $27.1M since 2015, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.